News and Press Releases

Press releases

Theralase Advances Intellectual Property of Anti-Cancer Technology

Toronto, Ontario – July 17, 2014 Theralase Technologies Inc. (“Theralase”) (TSXV: TLT) (TLTFF: OTC Link®) announced today that it has applie...

0

in the news

July 6, 2023

Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer

may 18, 2023

Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni

August 16, 2018

BTv – Theralase® an innovative medical technology for bladder cancer treatment – 2018

October 10, 2017

Invest in Ontario – Toronto-based Firm Advances Light-activated Cancer Treatment Through SOSCIP Collaboration Program

December 20, 2016

Stock News Now – Update with Theralase Technologies (TSX-V: TLT) (OTC PINK: TLTFF) December 2016

November 12, 2016

BTv – Theralase Technologies is Destroying Cancer Cells – 2016

February 12, 2016

BTv – Using Lasers to Heal Pain and Treat Cancer – 2016

August 31, 2015

The View From The C-Suite – Roger Dumoulin-White, P. Eng, President & CEO, Theralase Technologies Inc.

Theralase® newsletter

Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.